HBW Regulatory News: Canadian OTC Firm Warned On GMPs, Homeopathic Guidance Comment Extended
Executive Summary
FDA says Apollo Health And Beauty Care isn't meeting GMP requirements; and comment period on FDA draft guidance for oversight of homeopathic industry extended through March 23.
You may also be interested in...
HBW Market Roundup: Homeopathic Guidance Comments, Clif Bar Packages, ABC Awards, ZBiotics Funding
FDA extends deadline through 23 May for comments on draft guidance for homeopathic industry oversight; Clif Bar changes character on packaging for the first time in 28 years to honor female athletes; ABC announces Duke, Kronenberg and Champion awards; and probiotics firm ZBiotics raised funding for additional development.
FDA Adds Homeopathic Enforcement Details, Subtracts Compliance Policy Guide
Revised draft guidance identifies types of homeopathics posing "higher risks to public health." FDA withdraws 1988 compliance policy guide that allows homeopathic to be available even though they are not subject to pre-market approval or other review process agency imposes on all other drugs.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.